Scientists have genetically engineered a common bacteria found in the body in a way to target and destroy a potentially drug resistance harmful microbe. Researchers at Nanyang Technological University in Singapore developed a strain of harmless E. coli (Escherichia coli) bacteria that are able to detect and kill Pseudomonas aeruginosa, which is a leading cause of hospital acquired infections. P.aeurginosa is an opportunistic bacteria that lives in soil, water, and even in environments like hot tubs. For most healthy people, this bacteria seldom poses a problem but in patients with a weak immune system it may cause fatal infections that are resistant to a many powerful antibiotics. E. coli strains produce a protein called LasR, which recognizes molecules that P.aeurginosa bacteria use to communicate with one another. When LasR detects to these chemical signals, it switches on two genes. The first gene creates a toxin called pyocin that is lethal to P.aeeruginosa while the other gene orders the E. coli to break apart, which causes the release of more pyocin molecules, said lead researchers Nazanin Saeidi and Choon Kit Wong. Pyocin toxin is actually made and used by P.aeruginosa itself to kill other Pseudomonas competing strains. However, the scientists engineered the suicide E. coli to produce a form of pyocin called S5 that kill off the strains of P.aeruginosa responsible for most of the hospital infections. The suicide E.coli showed successful results in lab trials and managed to destroy 99 percent of targeted P.aeruginosa and even 90 percent of the drug resistant forms, the scientists reported in the journal Molecular Systems Biology. However, it may takes some years of developments and safety studies before using the new lethal weapon in animal and human trials. The scientists hope that the new proceeding may lead some day to new effective treatments for infections that are highly resistant to antibiotics.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkillerMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor